Brokerages expect that H.B. Fuller (NYSE:FUL – Get Rating) will announce $965.21 million in sales for the current quarter, Zacks reports. Four analysts have issued estimates for H.B. Fuller’s earnings. The lowest sales estimate is $955.80 million and the highest is $973.37 million. H.B. Fuller reported sales of $827.87 million during the same quarter last year, which would suggest a positive year over year growth rate of 16.6%. The company is scheduled to issue its next quarterly earnings report on Monday, January 1st.
On average, analysts expect that H.B. Fuller will report full year sales of $3.79 billion for the current year, with estimates ranging from $3.74 billion to $3.83 billion. For the next year, analysts anticipate that the firm will report sales of $3.97 billion, with estimates ranging from $3.89 billion to $4.04 billion. Zacks Investment Research’s sales averages are a mean average based on a survey of research analysts that cover H.B. Fuller.
H.B. Fuller (NYSE:FUL – Get Rating) last issued its quarterly earnings results on Wednesday, March 23rd. The specialty chemicals company reported $0.80 EPS for the quarter, topping the consensus estimate of $0.73 by $0.07. H.B. Fuller had a net margin of 5.39% and a return on equity of 12.40%. The firm had revenue of $856.50 million for the quarter, compared to analysts’ expectations of $817.92 million. During the same period in the previous year, the business earned $0.66 earnings per share. H.B. Fuller’s revenue for the quarter was up 18.0% compared to the same quarter last year.
In other H.B. Fuller news, VP Timothy J. Keenan sold 1,433 shares of H.B. Fuller stock in a transaction dated Friday, April 8th. The stock was sold at an average price of $68.25, for a total transaction of $97,802.25. Following the transaction, the vice president now owns 22,871 shares of the company’s stock, valued at approximately $1,560,945.75. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders own 4.69% of the company’s stock.
Several hedge funds and other institutional investors have recently made changes to their positions in FUL. Cramer Rosenthal Mcglynn LLC grew its stake in shares of H.B. Fuller by 21.3% in the 3rd quarter. Cramer Rosenthal Mcglynn LLC now owns 407,896 shares of the specialty chemicals company’s stock valued at $26,334,000 after buying an additional 71,523 shares in the last quarter. BNP Paribas Arbitrage SA grew its stake in shares of H.B. Fuller by 130.0% in the 3rd quarter. BNP Paribas Arbitrage SA now owns 56,816 shares of the specialty chemicals company’s stock valued at $3,668,000 after buying an additional 32,111 shares in the last quarter. Mutual of America Capital Management LLC grew its stake in shares of H.B. Fuller by 2.5% in the 4th quarter. Mutual of America Capital Management LLC now owns 7,179 shares of the specialty chemicals company’s stock valued at $581,000 after buying an additional 173 shares in the last quarter. Geode Capital Management LLC grew its stake in shares of H.B. Fuller by 5.0% in the 4th quarter. Geode Capital Management LLC now owns 872,252 shares of the specialty chemicals company’s stock valued at $70,652,000 after buying an additional 41,376 shares in the last quarter. Finally, Credit Suisse AG grew its stake in shares of H.B. Fuller by 2.6% in the 4th quarter. Credit Suisse AG now owns 47,819 shares of the specialty chemicals company’s stock valued at $3,873,000 after buying an additional 1,228 shares in the last quarter. 96.93% of the stock is owned by institutional investors and hedge funds.
Shares of H.B. Fuller stock opened at $65.02 on Friday. The company has a current ratio of 1.87, a quick ratio of 1.11 and a debt-to-equity ratio of 1.15. The company’s 50-day moving average price is $67.34 and its two-hundred day moving average price is $72.00. H.B. Fuller has a 52 week low of $59.17 and a 52 week high of $81.73. The stock has a market cap of $3.45 billion, a PE ratio of 19.41 and a beta of 1.61.
The firm also recently announced a quarterly dividend, which was paid on Thursday, May 5th. Shareholders of record on Thursday, April 21st were paid a dividend of $0.19 per share. This represents a $0.76 annualized dividend and a yield of 1.17%. The ex-dividend date was Wednesday, April 20th. This is a boost from H.B. Fuller’s previous quarterly dividend of $0.17. H.B. Fuller’s payout ratio is 22.69%.
About H.B. Fuller (Get Rating)
H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, additives, and other specialty chemical products worldwide. The company operates through three segments: Hygiene, Health and Consumable Adhesives; Engineering Adhesives; and Construction Adhesives.
- Get a free copy of the StockNews.com research report on H.B. Fuller (FUL)
- The Three Most Upgraded Stocks You Can Buy Now
- MarketBeat: Week in Review 5/9 – 5/13
- Is Electronic Arts (NASDAQ: EA) Suddenly A Safe Haven?
- Beyond Meat Stock Value is Improving
- The Travel Sector Is Getting Upgraded
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for H.B. Fuller Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for H.B. Fuller and related companies with MarketBeat.com's FREE daily email newsletter.